ASP546C

ASP546C · Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP546C, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors [Phase 1, Phase 2]

See pricing